Finance

Beta
Lists
GALE:VIE
Galenica AG
€89.90
-0.06%
(-0.050) 1D
Jun 3, 5:36:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for GALE...
Open
€90.05
High
€90.05
Low
€89.85
Mkt. cap
4.12B
Avg. vol.
4.00
Volume
0.00
52-wk high
€112.60
52-wk low
€89.20
No. of employees
7K
Open
€90.05
High
€90.05
Low
€89.85
Mkt. cap
4.12B
Avg. vol.
4.00
Volume
0.00
52-wk high
€112.60
52-wk low
€89.20
No. of employees
7K
News stories
From sources across the web
Profile
Galenica AG, headquartered in Bern, is an internationally active Swiss pharmaceutical and logistics company group, named after the ancient physician Galenus. It dates back to the 1927 Collaboration Pharmaceutique SA, a purchasing center for pharmaceutical products founded by 16 pharmacists in Clarens. This was renamed to Galenica AG in 1932 and moved from Vaud's Le Châtelard to Bern. The Galenica shares are listed on the SIX Swiss Exchange and are a component of the SMI MID index. Wikipedia
About Galenica AG
CEO-
Employees6.58K
Founded1927
Headquarters-
SectorHealth care provider
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.00B
1.00B
1.07B
1.07B
Cost of goods sold
874.63M
874.63M
946.00M
946.00M
Cost of revenue
874.63M
874.63M
946.00M
946.00M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
3.62M
3.62M
Operating expense
74.39M
74.39M
64.49M
64.49M
Total operating expenses
949.03M
949.03M
1.01B
1.01B
Operating income
52.91M
52.91M
60.49M
60.49M
Other non operating income
1.70M
1.70M
-2.72M
-2.72M
EBT including unusual items
53.25M
53.25M
57.93M
57.93M
EBT excluding unusual items
53.25M
53.25M
55.80M
55.80M
Income tax expense
8.93M
8.93M
10.32M
10.32M
Effective tax rate
16.77%
16.77%
17.80%
17.80%
Other operating expenses
46.83M
46.83M
30.33M
30.33M
Net income
44.14M
44.14M
46.41M
46.41M
Net profit margin
4.41%
4.41%
4.33%
4.33%
Earnings per share
-
-
-
-
Interest and investment income
310.00K
310.00K
199.00K
199.00K
Interest expense
-3.14M
-3.14M
-3.58M
-3.58M
Net interest expenses
-2.83M
-2.83M
-3.39M
-3.39M
Depreciation and amortization charges
27.56M
27.56M
30.54M
30.54M
EBITDA
67.11M
67.11M
66.62M
66.62M
Gain or loss from assets sale
-76.00K
-76.00K
-37.00K
-37.00K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more